Category: us corporate news

us corporate news

Aura Biosciences 2025 Annual Report: Advancing Bel-sar for Ocular and Urologic Oncology with Late-Stage Clinical Development

Minichart

March 30, 2026

Aura Biosciences 2025 Annual Report: Key Financial and Strat...

Continue Reading 0

us corporate news

USA Rare Earth, Inc. 2025 Annual Report: Building a Resilient Mine-to-Magnet Supply Chain for Critical Minerals and Rare Earth Elements

Minichart

March 30, 2026

USA Rare Earth, Inc. 2025 Annual Report: Key Insights for In...

Continue Reading 0

us corporate news

Entrepreneur Universe Bright Group 2025 Annual Report: Digital Marketing Consulting in China, Regulatory Risks, and Business Overview

Minichart

March 30, 2026

Entrepreneur Universe Bright Group (EUBG) Annual Report: Key...

Continue Reading 0

us corporate news

Vor Bio Annual Report 2025: Telitacicept Global Development Strategy, Regulatory Overview, and Summary Risk Factors

Minichart

March 30, 2026

Vor Biopharma Inc. 2025 Annual Report - Key Investor Insight...

Continue Reading 0

us corporate news

Scienture Holdings, Inc. 2025 Annual Report: Key Risks, Forward-Looking Statements, and Business Overview

Minichart

March 30, 2026

Scienture Holdings, Inc. 2025 Annual Report: Key Highlights ...

Continue Reading 0

us corporate news

Ondas Holdings: Integrated AI-Enabled Autonomous Systems & Mission Solutions for Defense, Security, and Critical Infrastructure

Minichart

March 30, 2026

Ondas Inc. 2025 Annual Report: Key Insights for Investors ...

Continue Reading 0

us corporate news

MeiraGTx 2025 Annual Report Highlights: Gene Therapy Pipeline, Strategic Partnerships, and Proprietary Riboswitch Platform

Minichart

March 30, 2026

MeiraGTx Holdings plc 2025 Annual Report – Investor Analysis...

Continue Reading 0

us corporate news

Allurion Technologies, Inc. 2025 Annual Report: Financial Performance, Stock Information, and SEC Filings

Minichart

March 30, 2026

Allurion Technologies 2025 Annual Report Highlights Allu...

Continue Reading 0

us corporate news

Tempest Therapeutics 2026 10-K: Pipeline Overview, CAR-T & Small Molecule Oncology Strategies, Key Partnerships, and Competitive Position

Minichart

March 30, 2026

Tempest Therapeutics, Inc. 2025 Annual Report: Detailed Inve...

Continue Reading 0

us corporate news

Envudeucitinib Shows Early, Robust Skin Clearance and Quality of Life Improvements in Phase 3 Plaque Psoriasis Trials by Alumis Inc. 123

Minichart

March 30, 2026

Alumis Inc. Reports Robust Phase 3 Results for Envudeucitini...

Continue Reading 0